New treatment option for Vestibular Schwannoma
Official title Early Rehabilitation Using Head Impulse Test for Acute Vestibular Deficit
ClinicalTrials.gov ID: NCT06660082
What this study is testing
- What it's testing
- The vestibulo-ocular reflex (VOR) induces a compensatory movement in the eye when the head is rotated, to maintain stable vision when we move. It originates in the peripheral vestibular system, which detects head movements.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- patients with unilateral vestibular schwannoma and programmed surgery
- vestibulo-ocular reflex gain :
- on pathological side \> 0.50
- on healthy side \> 0.80
- all information's concerning the study given more than 15 days before surgery and consent collected the day before surgery
You likely can't join if
- Radiotherapy treatment prior to surgery.
- Resumption of surgery
- Presence of bilateral vestibular schwannomas
- Normal or Corrected to normal distance visual acuity \< 5/10
- Presence of other aetiologies that may explain the ataxic syndrome and/or oscillopsias
- Oculomotor paralysis, ocular instability in primary position
See the full eligibility criteria
- patients with unilateral vestibular schwannoma and programmed surgery
- vestibulo-ocular reflex gain :
- on pathological side \> 0.50
- on healthy side \> 0.80
- all information's concerning the study given more than 15 days before surgery and consent collected the day before surgery
- Radiotherapy treatment prior to surgery.
- Resumption of surgery
- Presence of bilateral vestibular schwannomas
- Normal or Corrected to normal distance visual acuity \< 5/10
- Presence of other aetiologies that may explain the ataxic syndrome and/or oscillopsias
- Oculomotor paralysis, ocular instability in primary position
- Use of medications that compromise eye movement (psychotropic drugs)
- Cervical spinal pathology with instability (contraindication for vHIT)
- Cochlear implantation
- Non-stabilized medical condition
- Pregnant women. This exclusion criterion will be investigated by questioning the patient.
- Patient under guardianship
- Patient not affiliated to a social security scheme
- Patient participating any other treatment study
The study team makes the final eligibility decision.
Where it's taking place
- Bron, France
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bron, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.